Zileuton
NDC 64980-206, Zileuton, tablet, extended release, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-206
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204929
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-206 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZILEUTON600 mg/1
Pharmacologic classes
5-Lipoxygenase Inhibitor [EPC]; 5-Lipoxygenase Inhibitors [MoA]; Decreased Leukotriene Production [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-206-12 | 64980020612 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-206-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/fd382540-b390-4e86-a94a-988ea89c93a8NADAC price for package 64980020612
GET /v1/drugs/nadac/64980020612
Use it
Look up 64980-206 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-206 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-206. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.